Epigenetic inactivation of endothelin-2 and endothelin-3 in colon cancer

International Journal of Cancer

Volumn 132, Issue 5, 2013, Pages 1004-1012

  Wang, Rong ^a   Löhr, Christiane V ^b   Fischer, Kay ^b   Dashwood, W Mohaiza ^a   Greenwood, Jeffrey A ^b   Ho, Emily ^a,b   Williams, David E ^a,b   Ashktorab, Hassan ^c   Dashwood, Michael R ^d   Dashwood, Roderick H ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

colorectal cancer; DNA methylation; endothelin axis; epigenetics

Indexed keywords

ENDOTHELIN 2; ENDOTHELIN 3; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BISULFITE SEQUENCING; CANCER INVASION; CELL MIGRATION; COLON CANCER; CONTROLLED STUDY; DNA METHYLATION; EDN2 GENE; EDN3 GENE; EPIGENETIC INACTIVATION; EPIGENETICS; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYROSEQUENCING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA METHYLATION; SEQUENCE ANALYSIS;

ANIMALS; CACO-2 CELLS; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; DNA METHYLATION; ENDOTHELIN-2; ENDOTHELIN-3; EPIGENESIS, GENETIC; EPIGENOMICS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HCT116 CELLS; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; RATS; RNA, MESSENGER;

EID: 84872847300     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27762     Document Type: Article

References (17)

1. Wang R, Dashwood RH,. Endothelins and their receptors in cancer: identification of therapeutic targets. Pharmacol Res 2011; 63: 519-24.
2. Rosano L, Spinella F, Bagnato A,. The importance of endothelin axis in initiation, progression, and therapy of ovarian cancer. Am J Physiol Integr Comp Physiol 2010; 299: R395-R404.
3. Bhalla A, Haque S, Taylor I, et al. Endothelin receptor antagonism and cancer. Eur J Clin Invest 2009; 39 (Suppl 2): 74-7.
4. Thorin E, Clozel M,. The cardiovascular physiology and pharmacology of endothelin-1. Adv Pharmacol 2010; 60: 1-26.
5. Abraham D, Dashwood M,. Endothelin-role in vascular disease. Rheumatol 2008; 47 (Suppl 5): v23-4.
6. Grimshaw MJ, Naylor S, Balkwill FR,. Endothelin-2 is a hypoxia-induced autocrine survival factor for breast cancer cells. Mol Cancer Ther 2002; 1: 1273-81.
7. Grimshaw MJ,. Endothelins in breast tumour cell invasion. Cancer Lett 2005; 222: 129-38.
8. Sun de J, Liu Y, Lu DC, et al. Endothelin-3 growth factor levels decreased in cervical cancer compared with normal cervical epithelial cells. Hum Pathol 2007; 38: 1047-56.
9. Wiesmann F, Veeck J, Galm O, et al. Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer. Breast Cancer Res 2009; 11: R34.
10. Wang R, Dashwood WM, Nian H, et al. NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP). Int J Cancer 2011; 128: 2581-90.
11. Ling L, Maguire JJ, Davenport AP,. Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer. Br J Pharmacol, in press.
12. Knowles JP, Shi-Wen X, Haque SU, et al. Endothelin-1 stimulates colon cancer adjacent fibroblasts. Int J Cancer 2012; 130: 1264-72.
13. Said N, Smith S, Sanchez-Carbayo M, et al. Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer. J Clin Invest 2011; 121: 132-47.
14. Bianchi M, Adur J, Takizawa S, et al. Endothelin system in intestinal villi: a possible role of endothelin-2/vasoactive intestinal contractor in the maintenance of intestinal architecture. Biochem Biophys Res Commun 2012; 417: 1113-8.
15. Grimshaw MJ, Wilson JL, Balkwill FR,. Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors. Eur J Immunol 2002; 32: 2392-400.
16. Grimshaw MJ, Hagemann T, Ayhan A, et al. A role for endothelin-2 and its receptors in breast tumor cell invasion. Cancer Res 2004; 64: 2461-8.
17. Pao MM, Tsutsumi M, Liang G, et al. The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells. Hum Mol Genet 2001; 10: 903-10.